5-HT(1A)-MEDIATED LOWER LIP RETRACTION - EFFECTS OF 5-HT(1A) AGONISTS AND ANTAGONISTS

被引:26
作者
MOORE, NA
REES, G
SANGER, G
PERRETT, L
机构
[1] Lilly Research Centre, Eli Lilly and Co., Windlesham, Surrey GU20 6PH, Erl Wood Manor
关键词
8-OH-DPAT; 5-HT(1A) RECEPTORS; PINDOLOL; NAN190; LOWER LIP RETRACTION; RAT;
D O I
10.1016/0091-3057(93)90330-V
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
This study investigated the production of lower lip retraction (LLR) in the rat by the 5-hydroxytryptamine1A (5-HT1A) agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) and the effect of the putative 5-HT1A antagonists pindolol and (1-(2-methoxy-phenyl)-4-[4-(2-phthalimido)-butyl]-piperazine (NAN190). 8-OH-DPAT (0.125-1.0 mg/kg, IP) caused a dose-related increase in LLR. Pindolol (10-40 mg/kg, IP) and NAN190 (2.5-10 mg/kg, IP) produced a dose-related block of 8-OH-DPAT-induced LLR. Pindolol (10-40 mg/kg, IP) when administered alone was also found to cause LLR, suggesting that pindolol behaves as a partial agonist in this model. This was not the case with NAN 190 (2.5- 10 mg/kg, IP), which failed to produce LLR; however, NAN190 (2.5-10 mg/kg, IP) produced a dose-related block of the pindolol-induced LLR. These results clearly demonstrate that the LLR model can be used to detect 5-HT1A agonists, partial agonists, and antagonists.
引用
收藏
页码:141 / 143
页数:3
相关论文
共 11 条
[1]   ANTAGONISM OF 8-OH-DPAT-INDUCED BEHAVIOR IN RATS [J].
BERENDSEN, HHG ;
BROEKKAMP, CLE ;
VANDELFT, AML .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 187 (01) :97-103
[2]  
BRENDSEN HHG, 1989, PHARM BIOCH BEHAV, V33, P821
[3]   INVIVO INTERACTIONS OF NAN-190, A PUTATIVE SELECTIVE 5-HT1A ANTAGONIST, WITH IPSAPIRONE [J].
DEANS, C ;
LEATHLEY, M ;
GOUDIE, A .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 34 (04) :927-929
[4]   NAN-190 - AN ARYLPIPERAZINE ANALOG THAT ANTAGONIZES THE STIMULUS EFFECTS OF THE 5-HT1A AGONIST 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN (8-OH-DPAT) [J].
GLENNON, RA ;
NAIMAN, NA ;
PIERSON, ME ;
TITELER, M ;
LYON, RA ;
WEISBERG, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 154 (03) :339-341
[5]   IS PINDOLOL A MIXED AGONIST-ANTAGONIST AT CENTRAL SEROTONIN (5-HT) RECEPTORS [J].
HJORTH, S ;
CARLSSON, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 129 (1-2) :131-138
[6]   NAN-190 - AGONIST AND ANTAGONIST INTERACTIONS WITH BRAIN 5-HT1A RECEPTORS [J].
RYDELEKFITZGERALD, L ;
TEITLER, M ;
FLETCHER, PW ;
ISMAIEL, AM ;
GLENNON, RA .
BRAIN RESEARCH, 1990, 532 (1-2) :191-196
[7]   THE INVOLVEMENT OF SUBTYPES OF THE 5-HT1 RECEPTOR AND OF CATECHOLAMINERGIC SYSTEMS IN THE BEHAVIORAL-RESPONSE TO 8-HYDROXY-2-(DI-NORMAL-PROPYLAMINO)TETRALIN IN THE RAT [J].
TRICKLEBANK, MD ;
FORLER, C ;
FOZARD, JR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 106 (02) :271-282
[8]  
WILLIAMS AR, 1992, EUR J PHARMACOL, V219, P105, DOI 10.1016/0014-2999(92)90586-S
[9]   IS NAN-190 AN EFFECTIVE ANTAGONIST OF THE HYPOTHERMIA AND HYPERGLYCEMIA INDUCED BY THE 5-HT1A RECEPTOR AGONIST, 8-OH-DPAT [J].
WOZNIAK, KM ;
DURCAN, MJ ;
LINNOILA, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 193 (02) :253-256
[10]  
ZHANG L, 1991, BEHAV PHARMACOL, V2, P369